<DOC>
	<DOC>NCT02881359</DOC>
	<brief_summary>This study will assess the effectiveness of commercially available LifeSeal® Kit as measured by the incidence of post-operative clinical anastomotic leak rates in subjects undergoing low and ultralow anterior resection with an anastomosis. All patients treated with LifeSeal® will be offered to participate</brief_summary>
	<brief_title>SEAL Registry - European Registry for the Effectiveness of LifeSeal® Kit</brief_title>
	<detailed_description>The LifeSeal® Kit is a novel surgical sealant intended to be used as an adjunct to suture or staple line during standard surgical repair of the GI tract (anastomosis or linear) to provide re-inforcement and help reduce leaks. The LifeSeal™ Kit has recently been CE certified on March 2016 for marketing in the European Union.</detailed_description>
	<mesh_term>Anastomotic Leak</mesh_term>
	<criteria>1. ≥ 18 years of age at screening visit 2. Written informed consent obtained 3. Subject is scheduled to have or already underwent elective open, laparoscopic or robot assisted surgery involving the creation of a coloanal or colorectal anastomosis* created within 15 cm from the anal verge. 4. Subject was already treated or is scheduled to be treated with LifeSeal® Kit, applied according to the IFU 1. Subject with American Society of Anesthesiology (ASA) status &gt; 3.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>